Establishment Inspection-report

Showing of 1 - 20 from 10 results
Establishment Inspection-report - Total results - 10
Lupin gets inspection closure report from USFDA for Pithampur manufacturing plant in Madhya Pradesh
Business

Lupin gets inspection closure report from USFDA for Pithampur manufacturing plant in Madhya Pradesh

Drug maker Lupin on Thursday said the US health regulator has closed the inspection of its manufacturing facility in Pithampur, Madhya Pradesh

Biocon Biologics receives EIR from USFDA for two manufacturing facilities in Bengaluru
Business

Biocon Biologics receives EIR from USFDA for two manufacturing facilities in Bengaluru

Biocon Biologics India Ltd., a subsidiary of Biocon Ltd., said on Thursday it has received the Establishment Inspection Report (EIR) from the USFDA (the United States Food and Drug Administration) for the pre-approval inspection at two of its biologics manufacturing facilities in Bengaluru

Lupin's Mandideep Unit II facility in Madhya Pradesh receives EIR from USFDA
Business

Lupin's Mandideep Unit II facility in Madhya Pradesh receives EIR from USFDA

Pharma major Lupin on Wednesday said it has received an establishment inspection report (EIR) from the US health regulator for its Mandideep Unit II facility in Madhya Pradesh

Lupin gets EIR from USFDA for Nagpur plant; MD says committed to enhance compliance, quality standards at all sites
Business

Lupin gets EIR from USFDA for Nagpur plant; MD says committed to enhance compliance, quality standards at all sites

Drug maker Lupin on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant in Nagpur

Lupin gets Establishment Inspection Report from USFDA for Pithampur facility unit; stock falls 1.88%
Business

Lupin gets Establishment Inspection Report from USFDA for Pithampur facility unit; stock falls 1.88%

Drug firm Lupin on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for a unit of its Pithampur facility in Madhya Pradesh.

Lupin gets establishment inspection report from USFDA for its Nagpur facility
Business

Lupin gets establishment inspection report from USFDA for its Nagpur facility

Earlier in May, in a regulatory filing Lupin had said that the US health regulator had completed inspection of the Nagpur facility without making any observations.

Sun Pharma shares gain 4% after USFDA clears drug major; market cap rises by Rs 2,384 cr
Business

Sun Pharma shares gain 4% after USFDA clears drug major; market cap rises by Rs 2,384 cr

Shares of Sun Pharmaceutical Industries on Wednesday gained nearly 4 percent after the company received establishment inspection report (EIR) from the US health regulator for its Halol facility in Gujarat

Sun Pharma receives EIR for its crucial Halol plant in Gujarat, US health regulator clears drug major
Business

Sun Pharma receives EIR for its crucial Halol plant in Gujarat, US health regulator clears drug major

Sun Pharmaceutical Industries said it has received establishment inspection report (EIR) from US health regulator for its Halol facility in Gujarat

Cadila Healthcare gets EIR for Ahmedabad plant from USFDA
Business

Cadila Healthcare gets EIR for Ahmedabad plant from USFDA

The EIR report is given to an establishment after the completion of an inspection by the USFDA

Natco Pharma says USFDA clears inspection of its chemical division unit in Chennai
Business

Natco Pharma says USFDA clears inspection of its chemical division unit in Chennai

The USFDA released a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determines the inspection to be closed